Niagen Bioscience Inc

Research Niagen Bioscience Inc (NAGE) on Bullrun: market cap USD 212.26M, P/E 14.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerNAGE
ExchangeNASDAQ
CountryUnited States
SectorConsumer Defensive
IndustryPackaged Foods
CurrencyUSD
Market capUSD 212.26M
P/E14.3
Financial periodQ2 2026
RevenueUSD 29.79M
Net incomeUSD 963.00K
Free cash flowUSD 2.68M
Gross margin64.8%

Valuation Snapshot

latest market cap is USD 212.26M; P/E is 14.3.

Peer valuation comparison

Latest P/E is 14.3x versus a Consumer Defensive sector median of 17.24x (17.1% below).

Latest P/E is 14.3x versus a United States median of 23.85x (40.0% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	USD 129.42M	USD 17.38M	USD 13.21M	64.3%	0.2	USD 64.79M	USD 2.82M	USD 76.53M
FY2024	USD 99.60M	USD 8.55M	USD 11.95M	61.8%	0.11	USD 44.50M	USD 2.65M	USD 46.09M
FY2023	USD 83.57M	-USD 4.94M	USD 6.97M	60.8%	-0.07	USD 27.20M	USD 3.28M	USD 28.46M
FY2022	USD 72.05M	-USD 16.54M	-USD 15.43M	59.4%	-0.24	USD 20.30M	USD 4.26M	USD 28.67M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-09	USD 212.26M	14.3	n/a	n/a
2025	2025-12-31	USD 506.98M	31.8	n/a	n/a
2024	2024-12-31	USD 410.62M	48.3	n/a	n/a
2023	2023-12-29	USD 107.43M	n/a	n/a	n/a
2022	2022-12-30	USD 125.11M	n/a	n/a	n/a
2021	2021-12-31	USD 254.79M	n/a	n/a	n/a

About Niagen Bioscience Inc

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism;

Related stock research

United States stocks United States Consumer Defensive stocks A-Z stock index

Other Consumer Defensive stocks

B&G Foods Inc (BGS) BranchOut Food Inc (BOF) Bellring Brands Inc (BRBR) BRC Inc - Class A (BRCC) Bridgford Foods Corp (BRID) Beyond Meat Inc (BYND) Conagra Brands Inc (CAG) Central Garden & Pet Company (CENT) Clene Inc (CLNN) Campbell Soup Company (CPB) Darling Ingredients Inc (DAR) Dominion Diamond Corp (DDC)

Frequently asked questions

What is Niagen Bioscience Inc's market cap?

Niagen Bioscience Inc's market capitalization is USD 212.26M.

What is Niagen Bioscience Inc's P/E ratio?

Niagen Bioscience Inc's price-to-earnings (P/E) ratio is 14.3.

What does Niagen Bioscience Inc do?

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments.